First description of IncX3 NDM-5-producing plasmid within Escherichia coli ST448 in Mali.

Carbapenem resistance in Enterobacteriaceae has become an increasingly worrying threat. So far, no epidemiological data regarding NDM-producing enterobacterial isolates has been available on these strains in West Africa. The aim of this study was to seek for carbapenemase-producing Enterobacteriaceae clinical strains isolated in Bamako Teaching Hospital in Mali. Of 50 strains isolated between May 2016 and September 2016, we found a ST448 E. coli harbouring an IncX3 plasmid with bla NDM-5 embedded in the ΔISAba125-ble MBL structure. This study reports the first description of NDM-5 in Mali isolated in an undescribed ST E. coli in West Africa.

[The Hospital Wastewater Antibiotic Residues In Bamako (Mali)]. / Les Residus D'Antibiotiques Dans Les Effluents Hospitaliers De Bamako (Mali).

The aim of this study was to determine the wastewaters antibiotic residues concentration in two hospitals (CHU Point G and CHU Luxembourg) in Bamako. METHODS: The samples of wastewater were collected three times consecutively on three days every week at 9 a.m., 3 p.m. and 9 p.m. in 2016. The samples were stored at 4°C and transferred to the veterinary central laboratory (LCV). The antibiotic residues were detected by High Performance Liquid Chromatography and the antibiotic concentrations were determined by a spectrophotometer UV-Visible Hewlett Packard. RESULTS: The detected and measured antibiotic residues were amoxicillin ((0.066 ± 0.08 µg/l), erythromycin (0.04 ± 0.0 µg/l), co-trimoxazole (sulfamethoxazole 0.06 ± 0.21 µg/l + trimethoprime 0.08 ± 0.006 µg/l) and metronidazole (0.02 ± 0.0 µg/l in the hospital wastewater and in the sewer systems. Amoxicillin and sulfamethoxazole were detected before and after the Point G wastewater treatment. No antibiotic residue was detected in the "Chikoroni" sewer system which discharged the Point G wastewater. Amoxicillin and sulfamethoxazole were also detected in the wastewater of the hospital "le Luxembourg" which doesn't have a wastewater treatment plant and in the "Djafranako" sewer system which discharged the wastewater of this hospital. Erythromycin and metronidazole were detected only in the Point G wastewater. Chloramphenicol, ciprofloxacin and tetracyclin were not detected in the two hospital wastewater. The antibiotic residues concentrations at the different moments show the same high level in the different sites. CONCLUSION: Hospitals play a role in the antibiotic dissemination into the environment. In Bamako, the wastewater quality is not alarming, but every hospital must get a sewer system.

L'objectif de ce travail était de déterminer la concentration des résidus d'antibiotiques dans les effluents de deux hôpitaux de Bamako. MÉTHODES: La collecte des échantillons des effluents hospitaliers a été réalisée trois fois par jour à des heures précises : 9 heures, 15 heures et 21 heures conformément au moment des rejets de la station d'épuration, trois jours consécutifs par semaine et pendant un mois. L'analyse des échantillons a été faite par chromatographie phase liquide (HPLC), Agilent 1100 sur colonne C18. La concentration des antibiotiques a été mesurée à l'aide d'un spectrophotomètre UV-Visible Hewlett Packard. RÉSULTATS: Quatre antibiotiques ont été détectés et quantifiés dont trois régulièrement dans les effluents hospitaliers. Il s'agit de l'amoxicilline (0,066 ± 0,08 µg/l), l'érythromycine (0,04 ± 0,0 µg/l), sulfaméthoxazole + triméthoprime (0,06 ± 0,21 / 0,08 ± 0,006 µg/l) et du métronidazole (0,02 ± 0,0 µg/l). L'amoxicilline et le sulfaméthoxazole ont été détectés et quantifiés sur les deux points, l'érythromycine et le métronidazole seulement au CHU du Point « G ¼. Le sulfaméthoxazole a été dosé aux différentes heures dans les effluents des deux hôpitaux, il n'est pas détecté dans les eaux du canal de « Chikoroni ¼. Le chloramphénicol, la ciprofloxacine et la tétracycline n'ont été détectés à aucun point de prélèvement. Les concentrations d'antibiotiques observées aux différentes heures de prélèvements montrent des pics en général semblables au niveau des différents sites. CONCLUSION: La qualité de nos effluents n'est pas aussi alarmante. Des mesures doivent être prises en vue de l'évaluation du risque sanitaire et du développement des méthodes nécessaires pour limiter les rejets de résidus médicamenteux dans l'environnement.

Very high prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako, Mali.

The worldwide dissemination of extended-spectrum beta-lactamase producing Enterobacteriaceae, (ESBL-E) and their subset producing carbapenemases (CPE), is alarming. Limited data on the prevalence of such strains in infections from patients from Sub-Saharan Africa are currently available. We determined, here, the prevalence of ESBL-E/CPE in bacteriemic patients in two teaching hospitals from Bamako (Mali), which are at the top of the health care pyramid in the country. During one year, all Enterobacteriaceae isolated from bloodstream infections (E-BSI), were collected from patients hospitalized at the Point G University Teaching Hospital and the pediatric units of Gabriel Touré University Teaching Hospital. Antibiotic susceptibility testing, enzyme characterization and strain relatedness were determined. A total of 77 patients had an E-BSI and as many as 48 (62.3%) were infected with an ESBL-E. ESBL-E BSI were associated with a previous hospitalization (OR 3.97 95% IC [1.32; 13.21]) and were more frequent in hospital-acquired episodes (OR 3.66 95% IC [1.07; 13.38]). Among the 82 isolated Enterobacteriaceae, 58.5% were ESBL-E (20/31 Escherichia coli, 20/26 Klebsiella pneumoniae and 8/15 Enterobacter cloacae). The remaining (5 Salmonella Enteritidis, 3 Morganella morganii 1 Proteus mirabilis and 1 Leclercia adecarboxylata) were ESBL negative. CTX-M-1 group enzymes were highly prevalent (89.6%) among ESBLs; the remaining ones being SHV. One E. coli produced an OXA-181 carbapenemase, which is the first CPE described in Mali. The analysis of ESBL-E relatedness suggested a high rate of cross transmission between patients. In conclusion, even if CPE are still rare for the moment, the high rate of ESBL-BSI and frequent cross transmission probably impose a high medical and economic burden to Malian hospitals.

Prevalence of ESBL-producing Enterobacteriaceae isolated from blood cultures in Mali.

INTRODUCTION: The increasing frequency of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae is becoming a serious public health concern. This study sought to determine ESBL frequency in Enterobacteriaceae isolated from patients' blood cultures in two university teaching hospitals of Bamako, Mali. METHODOLOGY: During a three-month period, the presence of Enterobacteriaceae from blood cultures of patients admitted to the university teaching hospitals of Bamako was evaluated. The microbial identifications were initially performed with an API 20E gallery and VITEK2 locally in Mali, and then confirmation in France was performed with a mass spectrometry MALDI-TOF in the bacteriology laboratory of the university teaching hospital of Bichat. Antibiotic susceptibility profiles were determined by the diffusion method as recommended by the European Committee on Antimicrobial Susceptibility Testing (EUCAST). RESULTS: The isolated species were K. pneumoniae (14/40; 35.0%), E. coli (11/40; 27.5%), and E. cloacae (9/40; 22.5%). Of the strains isolated, 21/34 (61.8%) had an ESBL phenotype, including 10/14 (71.4%) K. pneumoniae, 8/11 (72.7%) E. coli, and 3/9 (33.3%) E. cloacae. Resistances associated with ESBL strains of K. pneumoniae, E. coli, and E. cloacae were as follows: gentamicin (10/10, 100%; 6/8, 75%; 2/3, 67%, respectively), amikacin (2/10, 20%; 0/8, 0%; 0/3, 0%, respectively), ofloxacin (8/10, 80%; 7/8, 87%; 3/3, 100%, respectively), and cotrimoxazole (10/10, 100%; 6/8, 75%; 3/3, 100%, respectively). CONCLUSION: Almost two-thirds (61.8%) of Enterobacteriaceae isolated from our blood cultures were ESBL producers. Only susceptibilities to carbapenems and to amikacin were fully conserved within the strains.